Perioperative Ketamine to Reduce Postoperative Delirium and Depression - The RECOGNISED Study
- Conditions
- DepressionDeliriumPostoperative Cognitive DysfunctionAnaesthesiology - AnaestheticsNeurological - DementiasSurgery - Other surgery
- Registration Number
- ACTRN12615001074583
- Lead Sponsor
- St Vincent's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 145
1. Patients age 60 years or older, scheduled for cardiac or major vascular surgery (greater than 2 hours).
2. Mini Mental State Examination score between 16 and 25
3. Provide written and informed consent.
4. Reside within reasonable prosimity to St Vincent's Hospital Melbourne for neuropsychological testing
1. Prior neurological deficit (eg Stroke)
2. Contraindication to neuropsychological testing such as language, visual or hearing impairment
3. Associated medical problems that may lead to significant complications and subsequent loss to follow-up
4. Anticipated ICU stay greater than 24 hours
5. Patients on psychoactive drugs (not antidepressants)
6. Patients unable to consent independently to their surgery on account of cognitive impairment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To measure the incidence of delirium using the 3 minute Diagnostic Confusion Assessment Method (3D-CAM) in the perioperative period after cardiac and major vascular surgery in patients with baseline cognitive impairment receiving ketamine compared to placebo.[Neuropsychological testing at baseline (prior to surgery), Day 7 and 3 months postoperatively.];To measure the incidence of depression in patients with baseline cognitive impairment given ketamine compared to placebo, postoperatively and at 3 months following cardiac and major vascular surgery.[Neuropsychological assessment at baseline, day 7 and 3 months.]
- Secondary Outcome Measures
Name Time Method